DOT & FMCSA Compliance for Employers of Commercial Drivers
Driver qualification files, medical certification, and DOT drug & alcohol testing — what motor carriers must do under 49 CFR Parts 40, 382, and 391.
- Testing rule
- 49 CFR Part 40 & Part 382
- Clearinghouse
- Annual query required per driver
- Random rates
- Set annually by FMCSA
Employers of commercial drivers must meet Federal Motor Carrier Safety Administration (FMCSA) requirements covering driver qualification, medical certification, and DOT drug and alcohol testing under 49 CFR Parts 40, 382, and 391.
The backbone of a compliant program is a complete driver qualification (DQ) file for each driver, a valid medical examiner's certificate, enrollment in and use of the Drug & Alcohol Clearinghouse, and a testing program covering pre-employment, random, reasonable-suspicion, post-accident, and return-to-duty scenarios.
DOT testing procedures in 49 CFR Part 40 are prescriptive — qualified collectors, SAMHSA-certified laboratories, and a Medical Review Officer (MRO) — and must be kept strictly separate from any non-DOT testing you run.
FMCSA compliance checklist
- Keep driver qualification files — Maintain a DQ file with application, MVR, road test, and medical certificate for each driver.
- Track medical certificates — Monitor expiration dates; FMCSA is moving medical certification to electronic transmission.
- Run DOT drug & alcohol testing — Pre-employment, random, reasonable-suspicion, post-accident, and return-to-duty testing under 49 CFR Part 382.
- Query the Clearinghouse — Run a full pre-employment query and annual queries for every driver, and report violations.
- Use compliant collection and MRO review — DOT-qualified collectors, certified labs, and a Medical Review Officer keep results defensible.
A starting point, not legal advice — verify against the primary sources cited below and current rules for your jurisdiction.
Key deadlines
- FMCSA paper medical certificate waiver expires
Motor carriers must transition to mandatory electronic medical certification or face enforcement.
- DOT directly observed collection rule in effect
Amended directly observed urine collection procedures under 49 CFR Part 40 are now enforceable.
Latest FMCSA coverage
- FMCSA Revokes 80th ELD Device: Mid-Year DOT Compliance Status Check for Motor Carriers
- DOT Drug and Alcohol Program Audit Readiness: A Mid-2026 Compliance Checkpoint for Motor Carriers
- FMCSA's Final Paper Medical Certificate Waiver Expires October 2026: What Motor Carriers Must Do Now
- New DOT Observed Collection Rule Takes Effect June 10, 2026: What Employers Must Know
- FMCSA's SMS Scoring Overhaul Is Here: What Every Motor Carrier Needs to Know in 2026
- FMCSA Has Revoked 67 ELD Devices Since 2025: What Motor Carriers Must Do Before Roadcheck 2026
- Marijuana Rescheduled to Schedule III: What Employers Must Do With Their Drug-Free Workplace Policies Now
- Congress Demands HHS Remove Barriers to DOT Oral Fluid Drug Testing: What Employers Must Know
- FMCSA Clearinghouse Violations Surpass 200,000: Escalating Penalties and What Fleet Operators Must Do Now
- FMCSA Withholds $73 Million from New York Over CDL Noncompliance: What Motor Carriers Need to Know
- CVSA International Roadcheck 2026: ELD Tampering and Cargo Securement Under the Spotlight
- DOT Drug Testing in 2026: Fentanyl Panel Expansion, Clearinghouse Phase II, and What CDL Employers Must Do Now
- Drug-Free Workplace Policies: What Employers Often Miss
Frequently Asked Questions
As of June 23, 2026, FMCSA has revoked 80 electronic logging devices from its registered list since January 2025. The most recent revocation was TRUCKSTAFF ELD, which carriers must replace by August 23, 2026.
Carriers using TRUCKSTAFF ELD have until August 23, 2026 — 60 days from the June 23 revocation date — to transition to a compliant ELD. During the grace period, drivers must use paper logs or approved logging software.
Not yet. DOT published a proposed rule (90 FR 42363) in September 2025 to add fentanyl and norfentanyl to the testing panel, but the final rule has not been published as of June 2026. Employers must continue using the current 5-panel test until the final rule takes effect.
No. While DOT has authorized oral fluid testing under 49 CFR Part 40, it cannot be used until at least two HHS-certified oral fluid laboratories are operational. As of June 2026, no such labs have been certified. Employers must continue with urine-based testing.
Carriers should verify their ELD is still on the FMCSA registered list, ensure DER protocols comply with the June 10 observed collection rule, monitor for the fentanyl final rule publication, and run Clearinghouse queries on all current drivers to confirm none are in prohibited status.
FMCSA audits can be triggered by elevated Safety Measurement System (SMS) scores in the Drug & Alcohol BASIC category, new entrant safety audit requirements, post-crash investigations, employee complaints, or random selection as part of ongoing enforcement.
The rule clarifies directly observed urine collection procedures when oral fluid testing is unavailable and updates terminology from 'gender' to 'sex' for observer-matching requirements per Executive Order 14168. Employers must update written policies to reflect these changes.
Employers must conduct a full pre-employment Clearinghouse query with driver consent before hiring, and a limited query on every current CDL driver at least once per calendar year. Failure to query before hiring can result in fines up to $7,500 per incident.